Ernexa Therapeutics Inc. Common Stock (ERNA) is a publicly traded Healthcare sector company. As of August 17, 2026, ERNA trades at $4.02 with a market cap of $4.98M and a P/E ratio of -1.79. ERNA moved +0.00% today. Year to date, ERNA is -85.77%; over the trailing twelve months it is -89.46%. Its 52-week range spans $3.18 to $360.00. Rallies surfaces ERNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ERNA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $4.02 |
| Market Cap | $4.98M |
| P/E Ratio | -1.79 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $360.00 |
| 52-Week Low | $3.18 |
| Volume | 21.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.08M |
| Gross Margin | 0.00% |
ERNA analyst coverage data. Average price target: $0.00.